Literatura académica sobre el tema "Primary muscle myoblasts"

The transplantation of cultured myoblasts into mature skeletal muscle is the basis for a new therapeutic approach to muscle and non-muscle diseases: myoblast-mediated gene therapy. The success of myoblast transplantation for correction of intrinsic muscle defects depends on the fusion of implanted cells with host myofibers. Previous studies in mice have been problematic because they have involved transplantation of established myogenic cell lines or primary muscle cultures. Both of these cell populations have disadvantages: myogenic cell lines are tumorigenic, and primary cultures contain a substantial percentage of non-myogenic cells which will not fuse to host fibers. Furthermore, for both cell populations, immune suppression of the host has been necessary for long-term retention of transplanted cells. To overcome these difficulties, we developed novel culture conditions that permit the purification of mouse myoblasts from primary cultures. Both enriched and clonal populations of primary myoblasts were characterized in assays of cell proliferation and differentiation. Primary myoblasts were dependent on added bFGF for growth and retained the ability to differentiate even after 30 population doublings. The fate of the pure myoblast populations after transplantation was monitored by labeling the cells with the marker enzyme beta-galactosidase (beta-gal) using retroviral mediated gene transfer. Within five days of transplantation into muscle of mature mice, primary myoblasts had fused with host muscle cells to form hybrid myofibers. To examine the immunobiology of primary myoblasts, we compared transplanted cells in syngeneic and allogeneic hosts. Even without immune suppression, the hybrid fibers persisted with continued beta-gal expression up to six months after myoblast transplantation in syngeneic hosts. In allogeneic hosts, the implanted cells were completely eliminated within three weeks. To assess tumorigenicity, primary myoblasts and myoblasts from the C2 myogenic cell line were transplanted into immunodeficient mice. Only C2 myoblasts formed tumors. The ease of isolation, growth, and transfection of primary mouse myoblasts under the conditions described here expand the opportunities to study muscle cell growth and differentiation using myoblasts from normal as well as mutant strains of mice. The properties of these cells after transplantation--the stability of resulting hybrid myofibers without immune suppression, the persistence of transgene expression, and the lack of tumorigenicity--suggest that studies of cell-mediated gene therapy using primary myoblasts can now be broadly applied to mouse models of human muscle and non-muscle diseases.

Intramuscular implanted myoblasts can fuse with existing myofibers. Here we report that implanted primary myoblasts marked with retroviral transgenes can also persist as muscle precursor cells. These cells can be recovered as viable myoblasts from muscles of recipient mice even months after myoblast implantation, and they can fully resume expression of the transgenes in culture. Upon re-implantation into muscles, they again not only fuse with existing myofibers, but also survive as muscle precursor cells in the tissue. These reserve myogenic cells should be able to contribute to host myofibers in muscle regeneration when the recombinant myofibers are damaged, providing an additional mechanism to maintain a persistent expression of transgenes delivered by myoblast-mediated gene transfer.

Mechanical unloading of skeletal muscles leads to the development of atrophic processes and a decrease in the total number of satellite cells (SCs) that are involved in muscle regeneration. In vitro studies revealed an increased differentiation of myoblasts derived from rat soleus muscle after an unloading-induced decrease in AMP-activated protein kinase (AMPK). AMPK is necessary for the activation of SCs and also participates in the regulation of myoblast proliferation and differentiation. It can be assumed that a decrease in the activity of AMPK after mechanical unloading can contribute to the acceleration of myoblast differentiation. The main purpose of this study was to elucidate a possible role of AMPK in the regulation of differentiation of myoblasts isolated from rat soleus muscle after mechanical unloading. To test this hypothesis, a specific AMPK activator, AICAR, was used to prevent a decrease in AMPK activity during differentiation of myoblasts isolated from rat soleus muscle after 7-day unloading. Immunocytochemistry, PCR-RT and Western blotting were used to assess changes during myoblast differentiation. In differentiating myoblasts derived from the unloaded soleus muscle there was a significant decrease in AMPK (Thr172) and ACC (Ser 79) phosphorylation levels, an increase in myotube differentiation index, myoblast fusion factors and the expression of myogenic regulatory factors (MRF). Furthermore, there was a decrease in the expression of slow myosin heavy chains (MyHC) and an increase in the expression of fast MyHC isoforms. AICAR treatment of differentiating myoblasts obtained from the unloaded soleus muscle prevented a decrease in AMPK and ACC phosphorylation, returned the expression levels of MRF and fast isoforms of MyHC to the control levels as well as maintained the expression of slow MyHC. Thus, abnormally accelerated differentiation of myoblasts isolated from atrophied rat soleus muscle can be compensated by maintaining the control levels of AMPK activity using AICAR.

Skeletal muscle stem cell–derived myoblasts are mainly responsible for postnatal muscle growth and injury-induced muscle regeneration. However, the cellular signaling pathways controlling the proliferation and differentiation of myoblasts are not fully understood. We demonstrate that Janus kinase 1 (JAK1) is required for myoblast proliferation and that it also functions as a checkpoint to prevent myoblasts from premature differentiation. Deliberate knockdown of JAK1 in both primary and immortalized myoblasts induces precocious myogenic differentiation with a concomitant reduction in cell proliferation. This is caused, in part, by an accelerated induction of MyoD, myocyte enhancer–binding factor 2 (MEF2), p21Cip1, and p27Kip1, a faster down-regulation of Id1, and an increase in MEF2-dependent gene transcription. Downstream of JAK1, of all the signal transducer and activator of transcriptions (STATs) present in myoblasts, we find that only STAT1 knockdown promotes myogenic differentiation in both primary and immortalized myoblasts. Leukemia inhibitory factor stimulates myoblast proliferation and represses differentiation via JAK1–STAT1–STAT3. Thus, JAK1–STAT1–STAT3 constitutes a signaling pathway that promotes myoblast proliferation and prevents premature myoblast differentiation.

Abstract Thyroid hormone plays an essential role in myogenesis, the process required for skeletal muscle development and repair, although the mechanisms have not been established. Skeletal muscle develops from the fusion of precursor myoblasts into myofibers. We have used the C2C12 skeletal muscle myoblast cell line, primary myoblasts, and mouse models of resistance to thyroid hormone (RTH) α and β, to determine the role of thyroid hormone in the regulation of myoblast differentiation. T3, which activates thyroid hormone receptor (TR) α and β, increased myoblast differentiation whereas GC1, a selective TRβ agonist, was minimally effective. Genetic approaches confirmed that TRα plays an important role in normal myoblast proliferation and differentiation and acts through the Wnt/β-catenin signaling pathway. Myoblasts with TRα knockdown, or derived from RTH-TRα PV (a frame-shift mutation) mice, displayed reduced proliferation and myogenic differentiation. Moreover, skeletal muscle from the TRα1PV mutant mouse had impaired in vivo regeneration after injury. RTH-TRβ PV mutant mouse model skeletal muscle and derived primary myoblasts did not have altered proliferation, myogenic differentiation, or response to injury when compared with control. In conclusion, TRα plays an essential role in myoblast homeostasis and provides a potential therapeutic target to enhance skeletal muscle regeneration.

The distribution of secondary myotubes and undifferentiated mononucleated cells (presumed to be myoblasts) within foetal IVth lumbrical muscles of the rat was analyzed with serial section electron microscopy. In all myotube clusters for which the innervation zone was located, every secondary myotube overlapped the end-plate region of the primary myotube. No secondary myotubes were ever demonstrated to occur at a distance from the primary myotube innervation zone. This indicates that new secondary myotubes begin to form only in the innervation zone of the muscle. Some young secondary myotubes made direct contact with a nerve terminal, but we cannot say if this is true for all developing secondary myotubes. Myoblasts were not clustered near the innervation zone, but were uniformly distributed throughout the muscle. Myoblasts were frequently interposed between a primary and a secondary myotube, in equally close proximity to both cell membranes. We conclude that specificity in myoblast-myotube fusion does not depend on restrictions in the physical distribution of myoblasts within the muscle, and therefore must reflect more subtle mechanisms for intercellular recognition.

Tissue regeneration depends on the complex processes of angiogenesis, inflammation and wound healing. Regarding muscle tissue, glucocorticoids (GCs) inhibit pro-inflammatory signalling and angiogenesis and lead to muscle atrophy. Our hypothesis is that the synthetic GC dexamethasone (dex) impairs angiogenesis leading to muscle atrophy or inhibited muscle regeneration. Therefore, this study aims to elucidate the effect of dexamethasone on HUVECs under different conditions in mono- and co-culture with myoblasts to evaluate growth behavior and dex impact with regard to muscle atrophy and muscle regeneration. Viability assays, qPCR, immunofluorescence as well as ELISAs were performed on HUVECs, and human primary myoblasts seeded under different culture conditions. Our results show that dex had a higher impact on the tube formation when HUVECs were maintained with VEGF. Gene expression was not influenced by dex and was independent of cells growing in a 2D or 3D matrix. In co-culture CD31 expression was suppressed after incubation with dex and gene expression analysis revealed that dex enhanced expression of myogenic transcription factors, but repressed angiogenic factors. Moreover, dex inhibited the VEGF mediated pro angiogenic effect of myoblasts and inhibited expression of angiogenic inducers in the co-culture model. This is the first study describing a co-culture of human primary myoblast and HUVECs maintained under different conditions. Our results indicate that dex affects angiogenesis via inhibition of VEGF release at least in myoblasts, which could be responsible not only for the development of muscle atrophy after dex administration, but also for inhibition of muscle regeneration after vascular damage.

Elevated plasma lipid and nonesterified fatty acid concentrations reduce insulin-mediated glucose disposal in skeletal muscle. Cultured myoblasts from 21 subjects were studied for rates of palmitate oxidation and the effect of palmitate on glycogen synthase activity at the end of an 18-h incubation in serum- and glucose-free media. Oxidation rates of 40 μM palmitate in cultured myoblasts correlated with the fasting glucose ( r = 0.71, P = 0.001), log fasting insulin ( r = 0.52, P = 0.03), and insulin-mediated glucose storage rate ( r = −0.50, P = 0.04) of the muscle donors. Myoblast glycogen synthase activity can be regulated by 240 μM palmitate, but the changes are associated with the basal respiratory quotient and not with the insulin resistance of the muscle donor. These results indicate that myoblasts producing elevated palmitate oxidation rates in vitro can be used to identify skeletal muscle abnormalities which are primary contributors to insulin resistance in vivo. Effects of 240 μM palmitate on myoblast glycogen synthase activity appear to be mechanistically different from the relationship between myoblast palmitate oxidation rates and insulin resistance of the muscle donor.

The quality and quantity of animal meat are closely related to the development of skeletal muscle, which, in turn, is determined by myogenic cells, including myoblasts and skeletal muscle satellite cells (SMSCs). Circular RNA, an endogenous RNA derivative formed through specific reverse splicing in mRNA precursors, has the potential to influence muscle development by binding to miRNAs or regulating gene expression involved in muscular growth at the transcriptional level. Previous high-throughput sequencing of circRNA in chicken liver tissue revealed a circular transcript, circIGF2BP3, derived from the gene encoding insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3). In this study, we confirmed the presence of the natural circular molecule of circIGF2BP3 through an RNase R enzyme tolerance assay. RT-qPCR results showed high circIGF2BP3 expression in the pectoral and thigh muscles of Yuexi frizzled feather chickens at embryonic ages 14 and 18, as well as at 7 weeks post-hatch. Notably, its expression increased during embryonic development, followed by a rapid decrease after birth. As well as using RT-qPCR, Edu, CCK-8, immunofluorescence, and Western blot techniques, we demonstrated that overexpressing circIGF2BP3 could promote the proliferation and differentiation of chicken primary myoblasts through upregulating genes such as proliferating cell nuclear antigen (PCNA), cyclin D1 (CCND1), cyclin E1 (CCNE1), cyclin dependent kinase 2 (CDK2), myosin heavy chain (MyHC), myoblast-determining 1 (MyoD1), myogenin (MyoG), and Myomaker. In conclusion, circIGF2BP3 promotes the proliferation and differentiation of myoblasts in chickens. This study establishes a foundation for further investigation into the biological functions and mechanisms of circIGF2BP3 in myoblasts proliferation and differentiation.

The CC genotype of the vitamin D receptor (VDR) polymorphism TaqI rs731236 has previously been associated with a higher risk of developing myopathy compared to TT carriers. However, the mechanistic role of this polymorphism in skeletal muscle is not well defined. The effects of vitamin D on patients genotyped for the VDR polymorphism TaqI rs731236, comparing CC and TT carriers were evaluated. Primary human myoblasts isolated from 4 CC carriers were compared with myoblasts isolated from four TT carriers and treated with vitamin D in vitro. A dose-dependent inhibitory effect on myoblast proliferation and differentiation was observed concurrent with modifications of key myogenic regulatory factors. RNA sequencing revealed a vitamin D dose–response gene signature enriched with a higher number of VDR-responsive elements (VDREs) per gene. Interestingly, the greater the expression of muscle differentiation markers in myoblasts, the more pronounced was the vitamin D-mediated response to suppress genes associated with myogenic fusion and myotube formation. This novel finding provides a mechanistic explanation to the inconsistency regarding previous reports of the role of vitamin D in myoblast differentiation. No effects in myoblast proliferation, differentiation or gene expression were related to CC vs TT carriers. Our findings suggest that the VDR polymorphism TaqI rs731236 comparing CC vs TT carriers did not influence the effects of vitamin D on primary human myoblasts and that vitamin D inhibits myoblast proliferation and differentiation through key regulators of cell cycle progression. Future studies need to employ strategies to identify the primary responses of vitamin D that drive the cellular response towards quiescence.

La famille Tead de facteurs de transcription reconnaît l'élément MCAT trouvé dans le promoteur de gènes spécifiques au muscle. L'analyse génétique de leur fonction dans la différenciation musculaire a révélé difficile en raison de la redondance susceptible parmi les membres de la famille. Dans cette étude, nous avons utilisé le silencing siRNA médiation pour aborder le rôle des facteurs TEAD dans la différenciation des myoblastes primaire.Contrairement aux cellules C2C12 où Tead4 joue un rôle essentiel, son silence dans les myoblastes primaires a eu peu d'effet sur leur différenciation. Silence de facteurs individuels TEAD n'a eu aucun effet significatif sur la différenciation des myoblastes primaires, alorsque le silençage combinatoire a conduit à l'inhibition de leur différenciation indiquant laredondance parmi ces facteurs. Dans les cellules C2C12 aussi, combinatoire silençageTead eu des effets beaucoup plus puissants que de faire taire Tead4 seule indiquant une contribution des autres Teads dans ce processus. En intégrant Tead1 et les données Tead4ChIP-Seq avec les données d'ARN-Seq suivante combinatoire Tead1 / 4 silencieux, nous identifions ensembles distincts, mais qui se chevauchent de gènes Tead réglementés dansles deux cellules C2C12 myoblastes et primaires. Nous avons également intégré les / 4 données Tead1 ChIP-seq avec des ensembles de données publiques sur Myog et MYOD1ChIP-Seq et chromatine modifications à identifier une série d'éléments de régulation actifsliés par des facteurs TEAD seul ou avec Myog et MYOD1. Ces données disséquer les fonctions spécifiques et combinatoires de ces facteurs de transcription dans les réseaux derégulation de le differentiation musculaire
The Tead family of transcription factors recognise the MCAT element found in thepromoters of muscle-specific genes. Genetic analysis of their function in muscledifferentiation has proved elusive likely due to redundancy amongst the family members.We previously used shRNA-mediated silencing to show that loss of Tead4 function resultedin abnormal differentiation characterised by the formation of shortened myotubes. ChIP-chipcoupled to RNA-seq data identified a set of potential target genes that are either activatedor repressed by Tead4 during differentiation. In this study, we have used siRNA-mediatedsilencing to address the role of the Tead factors in primary myoblast differentiation. Incontrast to C2C12 cells where Tead4 plays a critical role, its silencing in primary myoblastshad little effect on their differentiation. Silencing of individual Tead factors had no significanteffect on primary myoblast differentiation, whereas combinatorial silencing led to inhibitionof their differentiation indicating redundancy amongst these factors. In C2C12 cells also,combinatorial Tead silencing had much more potent effects than silencing of Tead4 aloneindicating a contribution of other Teads in this process. By integrating Tead1 and Tead4ChIP-seq data with RNA-seq data following combinatorial Tead1/4 silencing, we identifydistinct but overlapping sets of Tead regulated genes in both C2C12 cells and primarymyoblasts. We also integrated the Tead1/4 ChIP-seq data with public data sets on Myogand Myod1 ChIP-seq and chromatin modifications to identify a series of active regulatoryelements bound by Tead factors alone or together with Myog and Myod1. These datadissect the specific and combinatorial functions of these transcription factors in muscledifferentiation regulatory networks

L'objectif du projet de thèse était de mettre au point un modèle in vitro de myotubes humains différenciés et alignés pouvant être soumis à une tension mécanique. Pour cela, un hybride organique-inorganique, l'EETMOS [2-(3,4 epoxycyclohexylethyltrimethoxysilane)] a été microstructuré par photolithographie UV sur une membrane en PDMS. Cela permet de créer un support flexible avec en surface des lignes parallèles entre elles pouvant être ensuite étiré et tout en favorisant l'alignement des myotubes.L'EETMol est le produit de synthèse sol-gel, une méthode de chimie douce, de l'EETMOS en milieu acide. Ce sol est ensuite déposé par spin coating sur la surface préalablement activée par traitement plasma du PDMS. Les lignes sont ensuite tracées par photolithographie UV avec un laser de haute précision. Les supports microstructurés sont ensuite biofonctionnalisés avec des ligands à base de peptides d'adhésion issus de la matrice extracellulaire. Ceux-ci ont été spécialement synthétisés pour présenter des groupements silylés en surface afin de générer des liaisons covalentes avec le PDMS ce qui permet d'assurer une accroche solide des myotubes au support.L'espacement entre les microstructures ainsi que leur hauteur ont été optimisés pour favoriser le développement des myotubes humains. Après optimisation et analyse par immunofluorescence, des myotubes avec un diamètre de 30µm ont été obtenus sur des supports dont la hauteur des microstructures est de 8µm et leur espacement de 75µm.Enfin, un protocole d'étirement mécanique a été mis au point (10% d'amplitude, 1Hz, deux cycles d'une heure d'étirement, deux heures de repos, une heure d'étirement, séparés par 20h de repos). Un effet sur l'expression de facteurs de transcription myogéniques (MoyG) et sur certaines protéines du sarcomère a été observé suggérant un effet positif de ce protocole d'étirement sur la différenciation des myotubes humains.Ce modèle pourrait être utiliser dans le screening de biomolécules ou pour l'évaluation chez des patients, après micro-biopsie, de leur réponse musculaire au stress mécanique
Our aim was to propose an in vitro model of differentiated and aligned human skeletal myotubes. To this end, we describe the micropatterning on a PDMS [poly(dimethylsiloxane)] substrate of EETMOS [2-(3,4 epoxycyclohexylethyltrimethoxysilane)] an organic-inorganic hybrid polymer to produce a network of parallel lines that can be stretchable to optimize differenciation.The EETMOS-based resin was synthesized by sol-gel process and polymerized using UV-photolithography. Human primary myoblasts were seeded onto the microstructurated substrate to be, after proliferation, stretched to differentiate into aligned myotubes.The effect of the spacing between the parallel lines and their height was assessed by immunofluorescence. After an optimization of the model, we ended up with 30µm large myotubes reached with a 75µm spacing and 8 µm high microstructures. Then we functionalized the silicone with the use of silylated peptide ligands derived from extracellular matrix adhesion proteins to avoid detachment of the myotubes from their support. A stretching protocol was then optimized (10% from L0, 1Hz, two cycles of 1h stretching / 2h rest / 1h stretching with 20h rest in between). An improvement in the expression of sarcomere proteins and myogenic regulatory factors (MyoG) was observed with stretching in relation to better differentiation of the myogenic progeniteur. The in vitro model that we propose would be a very useful tool to evaluate in a patient, from a microbiopsy, his muscular responses to mechanical stress

La dystrophie musculaire facioscapulohumérale (FSHD) est une maladie autosomique dominante, caractérisée par une faiblesse et une atrophie progressive de certains muscles squelettiques. La FSHD est liée à une répression inefficace de la région des macrosatellites D4Z4 sur le chromosome 4, entraînant l'expression inappropriée dans le muscle squelettique, d’un gène à double homeobox 4 (DUX4), et la dérégulation des gènes avoisinants. La surexpression de DUX4 est responsable du phénotype atrophié des myotubes FSHD et induit la dérégulation de gènes impliqués dans la réponse au stress oxydant. Malgré les avancés majeures dans la compréhension du locus morbide, les mécanismes exacts impliqués dans la FSHD ne sont pas totalement compris et aucun traitement curatif n’est disponible. Cependant, de nombreuses données montrent le rôle prépondérant du stress oxydant dans la FSHD. Récemment, nous avons caractérisé la présence d’un stress oxydant dans les biopsies musculaires et les prélèvements sanguins des patients atteints de FSHD. Nous avons démontré que ce stress est corrélé à une altération de la fonction musculaire chez ces patients et qu’une supplémentation en antioxydants adaptée améliore la fonction musculaire et réduit les dommages oxydatifs. Par ailleurs, nous avons démontré que les myoblastes dérivés des biopsies FSHD sont plus sensibles à des agents pro-oxydants et présentent des défauts de différenciation. L’objectif de nos travaux est de caractériser les mécanismes moléculaires impliqués dans la FSHD afin de faciliter la mise en place d’approches thérapeutiques. Ce projet de thèse original réunit à la fois une approche fondamentale et clinique.Grâce à la mise en place d’un nouveau modèle in vitro de culture primaire de myoblastes de patients atteints de FSHD, nous avons montré la présence d’un stress oxydant dans ces myoblastes corroborant les observations précédemment obtenues aux niveaux systémiques et musculaires chez ces patients. Par ailleurs, les traitements par des agents pro-oxydants (paraquat et peroxyde d'hydrogène) ont un effet différentiel sur l’expression des enzymes antioxydantes par rapport aux contrôles suggérant un défaut dans les mécanismes d'adaptation au stress oxydant chez les patients atteints de FSHD.D’autre part, afin d'améliorer les procédures de réadaptation pour les patients atteints de FSHD, nous avons proposé d'étudier la faisabilité, la sécurité et l'efficacité de l’entraînement de force par électrostimulation neuromusculaire (ESNM) pour contrer la faiblesse musculaire des quadriceps chez ces patients. Cette étude, en cours, semble être une stratégie de réhabilitation prometteuse pour les patients atteints de FSHD et n’a montré aucun effets indésirables jusqu’à présent
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant disease, characterized by progressive weakness and atrophy of specific skeletal muscles. FSHD is linked to an inefficient repeat-mediated epigenetic repression of the D4Z4 macrosatellite repeat array on chromosome 4, resulting in the unappropriated expression in skeletal muscle of the double homeobox 4 (DUX4) retrogene. DUX4 overexpression leads to atrophic myotubes phenotype and dysregulation of antioxidant genes. Despite major progress in the understanding of the genetic locus, exact mechanisms that lead to FSHD defects are not completely understood and no curative treatment is available. However, several lines of evidence have proposed oxidative stress and myogenesis defect as the major biological processes affected in FSHD. Recently, we characterized oxidative stress in skeletal muscle biopsies and blood samples from patients with FSHD. We demonstrated that oxidative stress is associated with reduced physical performance in patients with FSHD and that antioxidants adapted strategy was effective to reduce oxidative stress and maintain muscle functions. Furthermore, satellite cell-derived myoblasts from these patients were more susceptible to pro-oxidant agents than control myoblasts and showed a defect in differentiation. The originality of this project relies on creating a synergy between basic and clinical research. The major goal of this work is to identify molecular mechanisms involved in FSHD oxidative stress in order to identify therapeutic approaches.Using in vitro cell model of FSHD, recently developed and optimized in our team, we demonstrate the presence of oxidative stress in FSHD primary myoblast cultures that corroborates previous observations at systemic and muscular levels. Furthermore, treatments with different pro-oxidant agents (paraquat and hydrogen peroxide) have a differential effect on the expression of antioxidant enzymes compared to controls, suggesting a defect in the oxidative stress adaptive response in FSHD myoblasts.Furthermore, in order to improve rehabilitation procedures for patients affected with FSHD, we proposed to investigate the feasibility, safety, and effectiveness of neuromuscular electrostimulation (NMES) strength training to counteract quadriceps muscle weakness in these patients. This ongoing study appears to be a promising rehabilitation strategy and shows no adverse effect for patients with FSHD

Urodele amphibians like the newt, are able to completely regenerate lost organs and appendages without scarring. Differentiated tissues are considered a reservoir for uncommitted blastema cells that participate in the regeneration of the lost structure. To determine the influence of the extracellular matrix (ECM) on the recruitment of progenitor cells from the skeletal muscle, we immunohistochemically mapped the limb in 3D and found that a transitional ECM rich in hyaluronic acid (HA), tenascin-C (TN) and fibronectin (FN) is dynamically expressed during the early stages of regeneration [1]. Functional in vitro testing of different ECM components on primary muscle cells revealed that HA and TN support myoblast migration, inhibit differentiation and enhance the fragmentation of multinucleate myotubes and production of viable mononucleate myoblasts, cellular behaviors necessary for blastema formation [1]. In contrast, myoblasts plated on matrices that mimic ECM around differentiated muscle (FN, Matrigel and laminin) induced both proliferation and fusion.